A Retrospective, Single-Arm, Observational Study in Patients with Multiple Sclerosis in India Receiving Ocrelizumab Therapy for 1 Year

MV Padma Srivastava, Joy Dev Mukherji, Anshu Rohatgi, Sameer Arora

Open source

DOI
10.4103/aian.aian_165_26
Published
2026-08-19
Container
Annals of Indian Academy of Neurology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/aian.aian_165_26,
  title = {A Retrospective, Single-Arm, Observational Study in Patients with Multiple Sclerosis in India Receiving Ocrelizumab Therapy for 1 Year},
  author = {MV Padma Srivastava and Joy Dev Mukherji and Anshu Rohatgi and Sameer Arora},
  year = {2026},
  journal = {Annals of Indian Academy of Neurology},
  doi = {10.4103/aian.aian_165_26},
  url = {https://doi.org/10.4103/aian.aian_165_26}
}

RIS

TY  - JOUR
TI  - A Retrospective, Single-Arm, Observational Study in Patients with Multiple Sclerosis in India Receiving Ocrelizumab Therapy for 1 Year
AU  - MV Padma Srivastava
AU  - Joy Dev Mukherji
AU  - Anshu Rohatgi
AU  - Sameer Arora
PY  - 2026
JO  - Annals of Indian Academy of Neurology
DO  - 10.4103/aian.aian_165_26
UR  - https://doi.org/10.4103/aian.aian_165_26
ER  - 

APA

Srivastava, M. P., Mukherji, J. D., Rohatgi, A., & Arora, S. (2026). A Retrospective, Single-Arm, Observational Study in Patients with Multiple Sclerosis in India Receiving Ocrelizumab Therapy for 1 Year. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_165_26

Source records